Bracebridge Capital, LLC - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L107. A total of 13 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
Bracebridge Capital, LLC ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$761,000
-74.5%
2,002,4950.0%0.12%
-45.5%
Q1 2022$2,984,000
-38.7%
2,002,4950.0%0.22%
-25.8%
Q4 2021$4,866,000
-54.4%
2,002,4950.0%0.30%
-68.3%
Q3 2021$10,673,000–2,002,495–0.94%–
 Download
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q3 2021
NameSharesValueWeighting ↓
Bracebridge Capital, LLC 2,002,495$4,866,0000.30%
Powell Investment Advisors, LLC 64,000$156,0000.09%
ARMISTICE CAPITAL, LLC 1,929,876$4,690,0000.08%
TUDOR INVESTMENT CORP ET AL 18,148$44,0000.00%
Tower Research Capital LLC (TRC) 12,923$31,0000.00%
Verition Fund Management LLC 30,000$73,0000.00%
Schonfeld Strategic Advisors LLC 20,800$51,0000.00%
WELLS FARGO & COMPANY/MN 25$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 2$00.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders